Ambea AB (AMBEA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ambea AB (AMBEA) has a cash flow conversion efficiency ratio of 0.417x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr2.17 Billion ≈ $233.42 Million USD) by net assets (Skr5.20 Billion ≈ $559.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ambea AB - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Ambea AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ambea AB debt and liabilities for a breakdown of total debt and financial obligations.
Ambea AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ambea AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Superloop Ltd
AU:SLC
|
0.123x |
|
Sichuan Huiyu Pharmaceutical Co Ltd
SHG:688553
|
0.016x |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
0.106x |
|
Metropolitan Kentjana Tbk
JK:MKPI
|
0.034x |
|
Playtika Holding Corp
NASDAQ:PLTK
|
-1.563x |
|
Corbion NV
AS:CRBN
|
0.063x |
|
Chengdu Information Technology of Chinese Academy of Sciences Co Ltd
SHE:300678
|
0.048x |
|
Everi Holdings Inc
NYSE:EVRI
|
1.295x |
Annual Cash Flow Conversion Efficiency for Ambea AB (2014–2025)
The table below shows the annual cash flow conversion efficiency of Ambea AB from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Ambea AB.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr5.20 Billion ≈ $559.60 Million |
Skr2.17 Billion ≈ $233.42 Million |
0.417x | +0.66% |
| 2024-12-31 | Skr4.99 Billion ≈ $536.57 Million |
Skr2.07 Billion ≈ $222.33 Million |
0.414x | +18.94% |
| 2023-12-31 | Skr4.92 Billion ≈ $529.47 Million |
Skr1.71 Billion ≈ $184.45 Million |
0.348x | +13.25% |
| 2022-12-31 | Skr4.68 Billion ≈ $503.75 Million |
Skr1.44 Billion ≈ $154.97 Million |
0.308x | +15.36% |
| 2021-12-31 | Skr4.53 Billion ≈ $487.50 Million |
Skr1.21 Billion ≈ $130.00 Million |
0.267x | -17.13% |
| 2020-12-31 | Skr4.33 Billion ≈ $465.55 Million |
Skr1.39 Billion ≈ $149.80 Million |
0.322x | +32.25% |
| 2019-12-31 | Skr4.04 Billion ≈ $434.34 Million |
Skr982.00 Million ≈ $105.68 Million |
0.243x | +22.42% |
| 2018-12-31 | Skr2.71 Billion ≈ $291.32 Million |
Skr538.00 Million ≈ $57.90 Million |
0.199x | +44.12% |
| 2017-12-31 | Skr2.48 Billion ≈ $266.89 Million |
Skr342.00 Million ≈ $36.80 Million |
0.138x | +35.74% |
| 2016-12-31 | Skr2.07 Billion ≈ $222.44 Million |
Skr210.00 Million ≈ $22.60 Million |
0.102x | -32.05% |
| 2015-12-31 | Skr1.93 Billion ≈ $208.02 Million |
Skr289.00 Million ≈ $31.10 Million |
0.150x | -25.92% |
| 2014-12-31 | Skr1.76 Billion ≈ $189.83 Million |
Skr356.00 Million ≈ $38.31 Million |
0.202x | -- |
About Ambea AB
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services fo… Read more